Cystadrops® (cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use Katherine A. Lyseng-Williamson Adis Drug Q&A 31 March 2017 Pages: 195 - 201
Kyleena™ (levonorgestrel-releasing intrauterine system) in contraception: a profile of its use Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A 21 March 2017 Pages: 202 - 207
Vaxelis® (DTaP5-HB-IPV-Hib vaccine) as primary and booster vaccination in infants and toddlers: a profile of its use Gillian M. KeatingKatherine A. Lyseng-WilliamsonYahiya Y. Syed Adis Drug Q&A 03 April 2017 Pages: 208 - 213
Treat juvenile idiopathic arthritis according to disease subtype and severity Adis Medical Writers Disease Management 31 March 2017 Pages: 214 - 221
When managing antipsychotic-induced somnolence, consider using lower-risk agents and promoting good sleep hygiene Adis Medical Writers Drug Reactions and Interactions 08 February 2017 Pages: 222 - 226
First reports of adverse drug reactions Drug Reactions and Interactions 24 March 2017 Pages: 227 - 227
Lactulose: a prebiotic, laxative and detoxifying agent Dhiren PranamiRamandeep SharmaHardik Pathak Review Article 17 February 2017 Pages: 228 - 233
‘Everyone plays defence’: a qualitative exploration of issues that influence the prescribing of antibiotics by Portuguese dentists Ana Sofia OliveiraMara Pereira Guerreiro Original Research Article 22 February 2017 Pages: 234 - 240